IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% SequentiallyPRNewsWire • 11/14/22
IM Cannabis' early mover status drives growth in multiple legal marketsProactive Investors • 11/11/22
IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis MarketPRNewsWire • 11/07/22
IM Cannabis to Report Third Quarter 2022 Financial Results on Monday, November 14 at 9:00am ETPRNewsWire • 11/01/22
IM Cannabis's Legacy Strain 'Roma' Voted Israel's Favourite Strain of the Month for August 2022PRNewsWire • 10/26/22
IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common SharesPRNewsWire • 10/06/22
SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to IsraelPRNewsWire • 09/15/22
IM Cannabis Corp. (IMCC) CEO Oren Shuster on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/15/22
IM Cannabis Corp. (IMCC) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/15/22
IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 MillionPRNewsWire • 08/15/22
Xinteza Unveils Disruptive Non-Cannabaceae Source for Cannabinoid Biosynthesis in Breakthrough Research Led by Prof. Asaph Aharoni at the Weizmann Institute of SciencePRNewsWire • 08/11/22
IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ETPRNewsWire • 08/04/22